Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Jermutus

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 1998
Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune librariesJ Hanes, L Jermutus, S Weber-Bornhauser, et al.
Advances in Protein Chemistry and Structural Biology|August 18, 2011
Aggregation, stability, and formulation of human antibody therapeuticsD Lowe, K Dudgeon, R Rouet, et al.
Journal of Biotechnology|February 13, 2001
Structure-based chimeric enzymes as an alternative to directed enzyme evolution: phytase as a test caseL Jermutus, M Tessier, L Pasamontes, et al.
Cell Death and Differentiation|January 21, 2012
A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potencyM Chodorge, S Züger, C Stirnimann, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2000
Unbinding forces of single antibody-antigen complexes correlate with their thermal dissociation ratesF Schwesinger, R Ros, T Strunz, et al.
British Journal of Pharmacology|August 24, 2012
Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritisR R Minter, E S Cohen, B Wang, et al.
Diabetes, Obesity & Metabolism|July 6, 2016
Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primatesS J Henderson, A Konkar, D C Hornigold, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 1998
Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune librariesJ Hanes, L Jermutus, S Weber-Bornhauser, et al.
Advances in Protein Chemistry and Structural Biology|August 18, 2011
Aggregation, stability, and formulation of human antibody therapeuticsD Lowe, K Dudgeon, R Rouet, et al.
Journal of Biotechnology|February 13, 2001
Structure-based chimeric enzymes as an alternative to directed enzyme evolution: phytase as a test caseL Jermutus, M Tessier, L Pasamontes, et al.
Cell Death and Differentiation|January 21, 2012
A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potencyM Chodorge, S Züger, C Stirnimann, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2000
Unbinding forces of single antibody-antigen complexes correlate with their thermal dissociation ratesF Schwesinger, R Ros, T Strunz, et al.
British Journal of Pharmacology|August 24, 2012
Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritisR R Minter, E S Cohen, B Wang, et al.
Diabetes, Obesity & Metabolism|July 6, 2016
Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primatesS J Henderson, A Konkar, D C Hornigold, et al.
Pageof 2